Many studies demonstrated that activation of TGF‐β signaling suppresses the development of atherosclerosis via regulating a variety of processes, including angiogenesis, VSMC proliferation and migration, inflammation, and foam cell formation (Grainger 2007; Chen et al. 2019b). This evidence concerns the gene TGFB1 and atherosclerosis.